OBJECTIVE: To investigate the therapeutic effect against tumor-involved axillary lymph nodes in rabbits bearing breast carcinoma with local administration of mitomycin C bound to activated carbon particles (MMC-CH). METHODS: Thirty female New Zealand white rabbits were divided into 3 groups randomly, with 10 in each. Breast carcinoma models were established by injecting VX2 tumor mass suspensions into the mammary gland of the rabbits. Treatment initiated once the axillary lymph node enlarged and attained 5 mm in the maximum diameter. Animals of Group A received a subcutaneous injection of MMC-CH adjacent to the implanted tumor. Group B received mitomycin C solution (MMC-Sol) and Group C received normal saline. The dose of mitomycin C was 0.2 mg/kg in Group A and Group B. The treatment was repeated every 48 hours. Axillary nodes were dissected after the third treatment. The therapeutic effects were compared in terms of the node volume ratio, necrosis and apoplosis of metastatic tumor cells in axillary nodes. The significance of differences was determined by ANOVA and Dunnett test. RESULTS: Compared with rabbits receiving MMC-Sol, a more apparent antitumor efficacy on metastasized nodes was observed in rabbits receiving subcutaneous injection of MMC-CH. After the treatment, the mean growth rates of nodes in Group A, B, and C were 2.645, 3.175, and 3.518, respectively. The differences between Group A and Group B or C were statistically significant (P=0.012 and P=0.000, respectively). The apoplotic indexes (AIs) in Group A, B, and C were 15.94%, 5.18%, and 4.60%, respectively. Significant difference was found between Group A and Group B (P=0.000), or Group B and C (P=0.02). Pathological examination revealed extensive necrosis of metastatic tumor cells in nodes of Group A. CONCLUSION: Local administration of MMC-CH appears to hold promising potential for the treatment of lymphatic metastases in rabbits bearing VX2 breast carcinoma.